Teva sues two Indian generics over Huntington’s treatment

06-07-2021

Alex Baldwin

Teva sues two Indian generics over Huntington’s treatment

Ralf Liebhold / Shutterstock.com

Teva Pharmaceuticals has filed lawsuits  in New Jersey against two Indian generics manufacturers to stop them from developing a generic version of its Huntington’s disease treatment.


Teva Pharmaceuticals, US District Court for the District of New Jersey on Thursday, patent infringement, Austedo, Lupin Pharmaceuticals, Aurobindo

LSIPR